Pulse lineResearch With Heart Logo

ARIC Publications

Filters: First Letter Of Last Name is S  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
1
Gorski M, van der Most PJ, Teumer A, et al. "1000 Genomes-based meta-analysis identifies 10 novel loci for kidney function." Sci Rep. 2017;7:45040.
Gorski M, van der Most PJ, Teumer A, et al. "1000 Genomes-based meta-analysis identifies 10 novel loci for kidney function." Sci Rep. 2017;7:45040.
Gorski M, van der Most PJ, Teumer A, et al. "1000 Genomes-based meta-analysis identifies 10 novel loci for kidney function." Sci Rep. 2017;7:45040.
Gorski M, van der Most PJ, Teumer A, et al. "1000 Genomes-based meta-analysis identifies 10 novel loci for kidney function." Sci Rep. 2017;7:45040.
Gorski M, van der Most PJ, Teumer A, et al. "1000 Genomes-based meta-analysis identifies 10 novel loci for kidney function." Sci Rep. 2017;7:45040.
Gorski M, van der Most PJ, Teumer A, et al. "1000 Genomes-based meta-analysis identifies 10 novel loci for kidney function." Sci Rep. 2017;7:45040.
Gorski M, van der Most PJ, Teumer A, et al. "1000 Genomes-based meta-analysis identifies 10 novel loci for kidney function." Sci Rep. 2017;7:45040.
Gorski M, van der Most PJ, Teumer A, et al. "1000 Genomes-based meta-analysis identifies 10 novel loci for kidney function." Sci Rep. 2017;7:45040.
Gorski M, van der Most PJ, Teumer A, et al. "1000 Genomes-based meta-analysis identifies 10 novel loci for kidney function." Sci Rep. 2017;7:45040.
Gorski M, van der Most PJ, Teumer A, et al. "1000 Genomes-based meta-analysis identifies 10 novel loci for kidney function." Sci Rep. 2017;7:45040.
Gorski M, van der Most PJ, Teumer A, et al. "1000 Genomes-based meta-analysis identifies 10 novel loci for kidney function." Sci Rep. 2017;7:45040.
Gorski M, van der Most PJ, Teumer A, et al. "1000 Genomes-based meta-analysis identifies 10 novel loci for kidney function." Sci Rep. 2017;7:45040.
Gorski M, van der Most PJ, Teumer A, et al. "1000 Genomes-based meta-analysis identifies 10 novel loci for kidney function." Sci Rep. 2017;7:45040.
Adib-Samii P, Rost N, Traylor M, et al. "17q25 Locus is associated with white matter hyperintensity volume in ischemic stroke, but not with lacunar stroke status." Stroke. 2013;44(6):1609-15.
Adib-Samii P, Rost N, Traylor M, et al. "17q25 Locus is associated with white matter hyperintensity volume in ischemic stroke, but not with lacunar stroke status." Stroke. 2013;44(6):1609-15.
Adib-Samii P, Rost N, Traylor M, et al. "17q25 Locus is associated with white matter hyperintensity volume in ischemic stroke, but not with lacunar stroke status." Stroke. 2013;44(6):1609-15.
5
van der Harst P, van Setten J, Verweij N, et al. "52 Genetic Loci Influencing Myocardial Mass." J Am Coll Cardiol. 2016;68(13):1435-1448.
van der Harst P, van Setten J, Verweij N, et al. "52 Genetic Loci Influencing Myocardial Mass." J Am Coll Cardiol. 2016;68(13):1435-1448.
van der Harst P, van Setten J, Verweij N, et al. "52 Genetic Loci Influencing Myocardial Mass." J Am Coll Cardiol. 2016;68(13):1435-1448.
van der Harst P, van Setten J, Verweij N, et al. "52 Genetic Loci Influencing Myocardial Mass." J Am Coll Cardiol. 2016;68(13):1435-1448.
van der Harst P, van Setten J, Verweij N, et al. "52 Genetic Loci Influencing Myocardial Mass." J Am Coll Cardiol. 2016;68(13):1435-1448.
van der Harst P, van Setten J, Verweij N, et al. "52 Genetic Loci Influencing Myocardial Mass." J Am Coll Cardiol. 2016;68(13):1435-1448.
van der Harst P, van Setten J, Verweij N, et al. "52 Genetic Loci Influencing Myocardial Mass." J Am Coll Cardiol. 2016;68(13):1435-1448.
van der Harst P, van Setten J, Verweij N, et al. "52 Genetic Loci Influencing Myocardial Mass." J Am Coll Cardiol. 2016;68(13):1435-1448.
van der Harst P, van Setten J, Verweij N, et al. "52 Genetic Loci Influencing Myocardial Mass." J Am Coll Cardiol. 2016;68(13):1435-1448.
van der Harst P, van Setten J, Verweij N, et al. "52 Genetic Loci Influencing Myocardial Mass." J Am Coll Cardiol. 2016;68(13):1435-1448.
van der Harst P, van Setten J, Verweij N, et al. "52 Genetic Loci Influencing Myocardial Mass." J Am Coll Cardiol. 2016;68(13):1435-1448.
van der Harst P, van Setten J, Verweij N, et al. "52 Genetic Loci Influencing Myocardial Mass." J Am Coll Cardiol. 2016;68(13):1435-1448.
van der Harst P, van Setten J, Verweij N, et al. "52 Genetic Loci Influencing Myocardial Mass." J Am Coll Cardiol. 2016;68(13):1435-1448.
van der Harst P, van Setten J, Verweij N, et al. "52 Genetic Loci Influencing Myocardial Mass." J Am Coll Cardiol. 2016;68(13):1435-1448.
van der Harst P, van Setten J, Verweij N, et al. "52 Genetic Loci Influencing Myocardial Mass." J Am Coll Cardiol. 2016;68(13):1435-1448.
van der Harst P, van Setten J, Verweij N, et al. "52 Genetic Loci Influencing Myocardial Mass." J Am Coll Cardiol. 2016;68(13):1435-1448.
van der Harst P, van Setten J, Verweij N, et al. "52 Genetic Loci Influencing Myocardial Mass." J Am Coll Cardiol. 2016;68(13):1435-1448.
van der Harst P, van Setten J, Verweij N, et al. "52 Genetic Loci Influencing Myocardial Mass." J Am Coll Cardiol. 2016;68(13):1435-1448.
van der Harst P, van Setten J, Verweij N, et al. "52 Genetic Loci Influencing Myocardial Mass." J Am Coll Cardiol. 2016;68(13):1435-1448.
van der Harst P, van Setten J, Verweij N, et al. "52 Genetic Loci Influencing Myocardial Mass." J Am Coll Cardiol. 2016;68(13):1435-1448.
van der Harst P, van Setten J, Verweij N, et al. "52 Genetic Loci Influencing Myocardial Mass." J Am Coll Cardiol. 2016;68(13):1435-1448.
van der Harst P, van Setten J, Verweij N, et al. "52 Genetic Loci Influencing Myocardial Mass." J Am Coll Cardiol. 2016;68(13):1435-1448.
A
Houston DK, Stevens J, Cai J. "Abdominal fat distribution and functional limitations and disability in a biracial cohort: the Atherosclerosis Risk in Communities Study." Int J Obes (Lond). 2005;29(12):1457-63.
Maheshwari A, Norby FL, Soliman EZ, et al. "Abnormal P-Wave Axis and Ischemic Stroke: The ARIC Study (Atherosclerosis Risk In Communities)." Stroke. 2017;48(8):2060-2065.
Huxley RR, Lopez FL, Folsom AR, et al. "Absolute and attributable risks of atrial fibrillation in relation to optimal and borderline risk factors: the Atherosclerosis Risk in Communities (ARIC) study." Circulation. 2011;123(14):1501-8.
Hozawa A, Folsom AR, A Sharrett R, Chambless LE. "Absolute and attributable risks of cardiovascular disease incidence in relation to optimal and borderline risk factors: comparison of African American with white subjects--Atherosclerosis Risk in Communities Study." Arch Intern Med. 2007;167(6):573-9.
Hunt KJ, Evans GW, Folsom AR, et al. "Acoustic shadowing on B-mode ultrasound of the carotid artery predicts ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) study." Stroke. 2001;32(5):1120-6.
Hunt KJ, Sharrett AR, Chambless LE, Folsom AR, Evans GW, Heiss G. "Acoustic shadowing on B-mode ultrasound of the carotid artery predicts CHD." Ultrasound Med Biol. 2001;27(3):357-65.
Amendola LM, Dorschner MO, Robertson PD, et al. "Actionable exomic incidental findings in 6503 participants: challenges of variant classification." Genome Res. 2015;25(3):305-15.
Amendola LM, Dorschner MO, Robertson PD, et al. "Actionable exomic incidental findings in 6503 participants: challenges of variant classification." Genome Res. 2015;25(3):305-15.
Amendola LM, Dorschner MO, Robertson PD, et al. "Actionable exomic incidental findings in 6503 participants: challenges of variant classification." Genome Res. 2015;25(3):305-15.
Amendola LM, Dorschner MO, Robertson PD, et al. "Actionable exomic incidental findings in 6503 participants: challenges of variant classification." Genome Res. 2015;25(3):305-15.
Amendola LM, Dorschner MO, Robertson PD, et al. "Actionable exomic incidental findings in 6503 participants: challenges of variant classification." Genome Res. 2015;25(3):305-15.
Amendola LM, Dorschner MO, Robertson PD, et al. "Actionable exomic incidental findings in 6503 participants: challenges of variant classification." Genome Res. 2015;25(3):305-15.
Amendola LM, Dorschner MO, Robertson PD, et al. "Actionable exomic incidental findings in 6503 participants: challenges of variant classification." Genome Res. 2015;25(3):305-15.
Howard G, Burke GL, Szklo M, et al. "Active and passive smoking are associated with increased carotid wall thickness. The Atherosclerosis Risk in Communities Study." Arch Intern Med. 1994;154(11):1277-82.
Millen AE, Sahli MW, Nie J, et al. "Adequate vitamin D status is associated with the reduced odds of prevalent diabetic retinopathy in African Americans and Caucasians." Cardiovasc Diabetol. 2016;15(1):128.
O'Connor LE, Hu EA, Steffen LM, Selvin E. "Adherence to a Mediterranean-style eating pattern and risk of diabetes in a U.S. prospective cohort study." Nutr Diabetes. 2020;10(1):8.
O'Connor LE, Hu EA, Steffen LM, Selvin E. "Adherence to a Mediterranean-style eating pattern and risk of diabetes in a U.S. prospective cohort study." Nutr Diabetes. 2020;10(1):8.
Hu EA, Wu A, Dearborn JL, et al. "Adherence to Dietary Patterns and Risk of Incident Dementia: Findings from the Atherosclerosis Risk in Communities Study." J Alzheimers Dis. 2020;78(2):827-835.
Hu EA, Wu A, Dearborn JL, et al. "Adherence to Dietary Patterns and Risk of Incident Dementia: Findings from the Atherosclerosis Risk in Communities Study." J Alzheimers Dis. 2020;78(2):827-835.
Haring B, Selvin E, He X, et al. "Adherence to the Dietary Approaches to Stop Hypertension Dietary Pattern and Risk of Abdominal Aortic Aneurysm: Results From the ARIC Study." J Am Heart Assoc. 2018;7(21):e009340.
Haring B, Selvin E, He X, et al. "Adherence to the Dietary Approaches to Stop Hypertension Dietary Pattern and Risk of Abdominal Aortic Aneurysm: Results From the ARIC Study." J Am Heart Assoc. 2018;7(21):e009340.
Hu EA, Steffen LM, Coresh JJ, Appel LJ. "Adherence to the Healthy Eating Index-2015 and Other Dietary Patterns May Reduce Risk of Cardiovascular Disease, Cardiovascular Mortality, and All-Cause Mortality." J Nutr. 2020;150(2):312-321.
Dearborn JL, Schneider ALC, Gottesman RF, et al. "Adiponectin and leptin levels in migraineurs in the Atherosclerosis Risk in Communities Study." Neurology. 2014;83(24):2211-8.
Duncan BB, Schmidt M I, Pankow JS, et al. "Adiponectin and the development of type 2 diabetes: the atherosclerosis risk in communities study." Diabetes. 2004;53(9):2473-8.
Chang AR, Grams ME, Ballew SH, et al. "Adiposity and risk of decline in glomerular filtration rate: meta-analysis of individual participant data in a global consortium." BMJ. 2019;364:k5301.
Fernandes-Silva MM, Shah AM, Claggett B, et al. "Adiposity, body composition and ventricular-arterial stiffness in the elderly: the Atherosclerosis Risk in Communities Study." Eur J Heart Fail. 2018;20(8):1191-1201.
Fernandes-Silva MM, Shah AM, Claggett B, et al. "Adiposity, body composition and ventricular-arterial stiffness in the elderly: the Atherosclerosis Risk in Communities Study." Eur J Heart Fail. 2018;20(8):1191-1201.
Fernandes-Silva MM, Shah AM, Claggett B, et al. "Adiposity, body composition and ventricular-arterial stiffness in the elderly: the Atherosclerosis Risk in Communities Study." Eur J Heart Fail. 2018;20(8):1191-1201.
Shakiba M, Soori H, Mansournia MAli, Nazari SSaeed Hash. "Adjusting for reverse causation to estimate the effect of obesity on mortality after incident heart failure in the Atherosclerosis Risk in Communities (ARIC) study." Epidemiol Health. 2016;38:e2016025.
Shakiba M, Soori H, Mansournia MAli, Nazari SSaeed Hash. "Adjusting for reverse causation to estimate the effect of obesity on mortality after incident heart failure in the Atherosclerosis Risk in Communities (ARIC) study." Epidemiol Health. 2016;38:e2016025.
Shakiba M, Soori H, Mansournia MAli, Nazari SSaeed Hash. "Adjusting for reverse causation to estimate the effect of obesity on mortality after incident heart failure in the Atherosclerosis Risk in Communities (ARIC) study." Epidemiol Health. 2016;38:e2016025.
Cheng C-Y, Reich D, Wong TY, et al. "Admixture mapping scans identify a locus affecting retinal vascular caliber in hypertensive African Americans: the Atherosclerosis Risk in Communities (ARIC) study." PLoS Genet. 2010;6(4):e1000908.